Walgreens Boots Alliance (WBA) announced that it has sold shares of Cencora (COR) pursuant to a share repurchase by Cencora in the amount of approximately $400M. With the transaction, Walgreens Boots Alliance’s ownership of Cencora’s common stock has decreased from approximately 13% to approximately 12%. Proceeds to Walgreens Boots Alliance will be used primarily for debt paydown and general corporate purposes, as the company continues to build out a more capital-efficient health services strategy rooted in its retail pharmacy footprint, to deliver care for communities and create value for partners. The sale has no impact to the long-term partnership between the two companies. Walgreens Boots Alliance remains fully committed to the strategic, mutually beneficial relationship with Cencora, which has been a strong and trusted partner since 2013. COO, International of Walgreens Boots Alliance, Ornella Barra, will continue to serve on Cencora’s Board of Directors.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WBA:
- Ex-Dividend Date Nearing for These 10 Stocks – Week of May 20, 2024
- Walgreens brand Naloxone available online and in stores in May
- Walgreens working with advisers on Boots sale, Bloomberg reports
- Early notable gainers among liquid option names on May 13th
- Walgreens jumps 6% to $18.29 after Bloomberg report of Boots sale process